부산대학교 도서관

Sissung, Tm; Price, Dk; DEL RE, MARZIA; Ley, Am; GIOVANNETTI, ELISA; Figg, Wd; DANESI, ROMANO

Sissung, T M, Price, D K, Del Re, M, Ley, A M, Giovannetti, E, Figg, W D & Danesi, R 2014, 'Genetic variation: effect on prostate cancer', Biochimica et Biophysica Acta. Reviews on Cancer, vol. 1846, no. 2, pp. 446-456. https://doi.org/10.1016/j.bbcan.2014.08.007

SISSUNG TM; DANESI, ROMANO; KIRKLAND CT; BAUM CE; OCKERS SB; STEIN EV; VENZON D; PRICE DK; FIGG WD

The Journal of Clinical Endocrinology & Metabolism. 96:E368-E372

JAIN L; VARGO CA; DANESI, ROMANO; SISSUNG TM; PRICE DK; VENZON D; VENITZ J; FIGG WD

Molecular Cancer Therapeutics. 8:2496-2508

SISSUNG TM; DANESI, ROMANO; PRICE DK; STEINBERG SM; DE WIT R; ZAHID M; GAIKWAD N; CAVALIERI E; DAHUT WL; SACKETT DL; FIGG WD; SPARREBOOM A.

Molecular Cancer Therapeutics. 7:19-26

BEVERAGE JN; SISSUNG TM; SION AM; DANESI, ROMANO; FIGG WD

Journal of Pharmaceutical Sciences. 96:2224-2231

Sparreboom, A; Loos, Walter; Burger, Herman; Sissung, TM; Verweij, Jaap; Figg, WD; Nooter, K (Kees); Gelderblom, H

Cancer Biology and Therapy. 4(6):650-653

PASTINA I; GIOVANNETTI E; CHIONI A; SISSUNG TM; CREA F; ORLANDINI C; PRICE, DK; CIANCI C; FIGG WD; RICCI S; DANESI, ROMANO

BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 511 (2010)
Pastina, I, Giovannetti, E, Chioni, A, Sissung, T M, Crea, F, Orlandini, C, Price, D K, Cianci, C, Figg, W D, Ricci, S & Danesi, R 2010, 'Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients', BMC Cancer, vol. 10, pp. 511. https://doi.org/10.1186/1471-2407-10-511

Sissung, TM; English,Bevin; Baum,Caitlin; Adelberg,D E; Sissung,TM; Kluetz,Paul; Dahut,William; Price,D K; Figg,WD

Ther Clin Risk Manag

Smith NF; Mani S; Schuetz EG; Yasuda K; Sissung TM; Bates SE; Figg WD; Sparreboom A; Smith, Nicola F; Mani, Sridhar; Schuetz, Erin G; Yasuda, Kazuto; Sissung, Tristan M; Bates, Susan E; Figg, William D; Sparreboom, Alex

Annals of Pharmacotherapy (ANN PHARMACOTHER), Nov2010; 44(11): 1709-1717. (9p)

Sissung, TM; Price, DK; Sparreboom, A; Figg, WD

MOLECULAR CANCER RESEARCH; MAR 2006, 4 3, p135-p150, 16p.

Sparreboom, A; Loos, WJ; Burger, H; Sissung, TM; Verweij, J; Figg, WD; Nooter, K; Gelderblom, H

CANCER BIOLOGY & THERAPY; JUN 2005, 4 6, p650-p653, 4p.

Sissung TM; Mross K; Steinberg SM; Behringer D; Figg WD; Sparreboom A; Mielke S

European Journal of Cancer (EUR J CANCER), Nov2006; 42(17): 2893-2896. (4p)

Sissung, TM; Danesi, R; Price, DK; Steinberg, SM; De Wit, R; Cox, MC; Dahut, W; Figg, W; Sparreboom, A

PHARMACOTHERAPY; OCT 2005, 25 10, p1479-p1479, 1p.

Similuk MN; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Bannon SA; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Yan J; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Ghosh R; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Damskey EE; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Beers BJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Orellana H; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Byers S; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Srinivasan S; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Kamen MJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Jodarski C; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Moses RG; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Reynolds-Lallement NC; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Lewis KL; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Seifert BA; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Tokita MJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Lack JB; NIAID Collaborative Bioinformatics Resource (NCBR), National Cancer Institute, National Institutes of Health, Bethesda, MD.; Cao W; NIAID Collaborative Bioinformatics Resource (NCBR), National Cancer Institute, National Institutes of Health, Bethesda, MD.; Sissung TM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Figg WD Sr; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Dimitrova D; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Kanakry JA; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Hickstein DD; Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Shah NN; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Gonzalez CE; Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Hughes TE; Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD.; Zerbe CS; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Su HC; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Freeman AF; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Uzel G; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; De Ravin SS; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Kang EM; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Malech HL; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Rao VK; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Lisco A; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Fuss IJ; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Cohen JI; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Durkee-Shock JR; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Delmonte OM; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Bergerson JRE; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Johnston JJ; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.; Biesecker LG; Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.; Kuijpers TW; Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Notarangelo LD; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Holland SM; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Walkiewicz MA; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6080 (Electronic) Linking ISSN: 00411337 NLM ISO Abbreviation: Transplantation Subsets: MEDLINE

Meany HJ; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia.; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.; Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Hinds PS; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia.; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.; Division of Nursing, Children's National Hospital, Washington, District of Columbia.; Bagatell R; Perelman School of Medicine, Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania.; Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, Massachusetts.; Stern E; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia.; Jayaprakash N; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Peer CJ; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Hall OM; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Sissung TM; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Kim A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia.; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.; Fox E; Perelman School of Medicine, Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania.; London WB; Dana-Farber/Boston Children's Cancer and Blood Disorder Center and Harvard Medical School, Boston, Massachusetts.; Rodriguez-Galindo C; Departments of Oncology and Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.; Minturn JE; Perelman School of Medicine, Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania.; Dome JS; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia.; The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.

Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

Flegel WA; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.; Srivastava K; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.; Sissung TM; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Goldspiel BR; Clinical Trials Operations and Informatics Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Figg WD; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Publisher: Blackwell Science Country of Publication: England NLM ID: 0413606 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0410 (Electronic) Linking ISSN: 00429007 NLM ISO Abbreviation: Vox Sang Subsets: MEDLINE

Sissung TM; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Lochrin S; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Liu T; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Schmidt K; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Strope J; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Risdon E; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Choo-Wosoba H; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Venzon DJ; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Lassoued W; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Sater HA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Walter-Rodriguez B; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Price DK; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A. figgw@mail.nih.gov.; Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, U.S.A.

Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

Strope JD; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA.; Lochrin SE; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA.; Sissung TM; Clinical Pharmacology Program, National Cancer Institute, National Institute of Health, Bethesda, USA.; Kem R; Cancer Therapy Evaluation Program, National Cancer Institute, National Institute of Health, Bethesda, USA.; Chandrasekaran P; National Institutes of Aging, National Institute of Health, Bethesda, USA.; Sharon E; Cancer Therapy Evaluation Program, National Cancer Institute, National Institute of Health, Bethesda, USA.; Price DK; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA.; Uldrick TS; Division of Medical Oncology, Vaccine and Infectious Disease Division, Division of Global Oncology, Department of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Yarchoan R; HIV/AIDS Malignancy Branch, National Cancer Institute, National Institute of Health, Bethesda, USA.; Figg WD; Molecular Pharmacology Section, National Cancer Institute, National Institute of Health, Bethesda, USA.

Publisher: Permanyer Publications Country of Publication: Spain NLM ID: 101134876 Publication Model: Print Cited Medium: Internet ISSN: 1698-6997 (Electronic) Linking ISSN: 11396121 NLM ISO Abbreviation: AIDS Rev Subsets: MEDLINE

Baker SD; College of Pharmacy, The Ohio State University, Columbus, OH.; Bates SE; Herbert Irving Comprehensive Cancer Center, Columbia University, Irving Medical Center, New York, NY.; Brooks GA; Dartmouth Cancer Center, Geisel School of Medicine, Lebanon, NH.; Dahut WL; American Cancer Society, Atlanta, GA.; Diasio RB; College of Medicine and Science, Mayo Clinic, Rochester, MN.; El-Deiry WS; Legorreta Cancer Center, Brown University, Providence, RI.; Evans WE; St. Jude Children's Research Hospital, Memphis, TN.; Figg WD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD.; Hertz DL; College of Pharmacy, University of Michigan, Ann Arbor, MI.; Hicks JK; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.; Kamath S; Cleveland Clinic, Lerner College of Medicine, Cleveland, OH.; Kasi PM; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY.; Knepper TC; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.; McLeod HL; Intermoutain Healthcare, St George, UT.; O'Donnell PH; The University of Chicago, Chicago, IL.; Relling MV; St. Jude Children's Research Hospital, Memphis, TN.; Rudek MA; School of Medicine, Johns Hopkins University, Baltimore, MD.; Sissung TM; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD.; Smith DM; Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Georgetown University, Washington, DC.; Sparreboom A; College of Pharmacy, The Ohio State University, Columbus, OH.; Swain SM; Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Georgetown University, Washington, DC.; Walko CM; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Strope JD; Molecular Pharmacology Section, National Cancer Institute, Bethesda, MD, USA.; Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD, USA.; Sissung TM; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD, USA.; Hall OM; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD, USA.; Huang PA; Molecular Pharmacology Section, National Cancer Institute, Bethesda, MD, USA.; Harris EM; Molecular Pharmacology Section, National Cancer Institute, Bethesda, MD, USA.; Gustafson KR; Molecular Targets Program, National Cancer Institute, Frederick, MD, USA.; Henrich CJ; Molecular Targets Program, National Cancer Institute, Frederick, MD, USA.; Basic Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Sigano DM; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.; Pauly GT; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.; Schneider JP; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.; Bates SE; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY, USA.; Figg WD; Molecular Pharmacology Section, National Cancer Institute, Bethesda, MD, USA.; Clinical Pharmacology Program, National Cancer Institute, Bethesda, MD, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE